Looking Ahead In my next article, Ill dive deeper into specific exercise recommendations for individuals who are overweight, obese, or experiencing extreme obesityincluding safety tips and tailored routines
GLP-1 medications are associated with a small increased risk of diabetic retinopathy progression in patients with pre-existing eye disease, particularly during rapid blood glucose improvement
Important warnings include thyroid tumor risk, pancreatitis, gallbladder disease, dehydration-related kidney injury, and hypoglycemia when used with insulin or sulfonylureas
Patients taking GLP-1 medications in combination with insulin or sulfonylureas face higher risk
Patients often experience chronic nausea, vomiting, bloating, abdominal pain, malnutrition, and unstable blood sugar levels
Adequate protein intake and targeted supplementation may help mitigate this